ArabFinance: Alexandria Company for Pharmaceuticals and Chemical Industries (Alex Pharma) (AXPH) announced that its board of directors has approved the companys income statement for the period starting July 1st until November 30th, 2021, according to a statement filed to the Egyptian Exchange (EGX).

The income statement showed that the company achieved a net profit after tax of EGP 45.38 million in the first five months of fiscal year (FY) 2021/2022, down by 30% year-on-year (YoY) from EGP 64.80 million.

It is worth noting that the listed company reported a 26.06% year-on-year drop in net profit after tax for the first quarter (Q1) of FY 2021/2022, recording EGP 33.23 million.

Alex Pharma, a subsidiary of Drug Holding Company, is an Egypt-based company engaged in the manufacture, development, and marketing of pharmaceutical, chemical, veterinary, and nutritional food products, as well as medical appliances.

Copyright 2022 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an as is and as available basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.